Sign in

CIK 0001347178

  • Accelerated filer

Vanda Pharmaceuticals Inc.

Sign in to watch
Ticker
VNDA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
030491827
Phone
+1 202-734-3400
Business address
2200 PENNSYLVANIA AVE NW, SUITE 300E, WASHINGTON, DC, 20037
Open-market buys, last 90 days
$38,094
in 1 filing
Open-market sales, last 90 days
$0
in 0 filings

Net +$38,094. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Duncan Charles Cliff +$38K Director 1 filing

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2019-10-28 Ward Anne Sempowski Director Grant or award · Stock Option (right to buy) +35,000 35,000
2019-08-26 DUGAN RICHARD W Director Option exercise +15,000 $14.78 $222K 50,770
2019-08-26 DUGAN RICHARD W Director Sale −15,000 $14.85 $223K 35,770
2019-08-26 DUGAN RICHARD W Director Option exercise · Nonstatutory Stock Option (Right to Buy) −15,000 0
2019-08-19 Wijkstrom Joakim SVP, Chief Marketing Officer Grant or award +30,000 30,000
2019-08-19 Wijkstrom Joakim SVP, Chief Marketing Officer Grant or award · Stock Option (Right to Buy) +90,000 90,000
2019-08-14 Williams Timothy SVP & General Counsel Sale −2,575 $14.69 $38K 57,425
2019-06-13 Watkins Thomas Director Grant or award +5,000 30,000
2019-06-13 Watkins Thomas Director Grant or award · Stock Option (Right to Buy) +10,000 10,000
2019-06-13 DUGAN RICHARD W Director Grant or award +5,000 35,770
2019-06-13 DUGAN RICHARD W Director Grant or award · Stock Option (Right to Buy) +10,000 10,000
2019-06-13 COLA MICHAEL F Director Grant or award +5,000 15,000
2019-06-13 COLA MICHAEL F Director Grant or award · Stock Option (Right to Buy) +10,000 10,000
2019-06-13 Chrousos Phaedra Director Grant or award +5,000 5,000
2019-06-13 Chrousos Phaedra Director Grant or award · Stock Option (Right to Buy) +10,000 10,000
2019-05-21 Polymeropoulos Mihael Hristos President and CEO Option exercise +79,019 $12.55 $992K 1,284,327
2019-05-21 Polymeropoulos Mihael Hristos President and CEO Sale −72,872 $15.34 $1.1M 1,211,455
2019-05-21 Polymeropoulos Mihael Hristos President and CEO Option exercise · Employee Stock Option (Right to Buy) −79,019 0
2019-05-20 Polymeropoulos Mihael Hristos President and CEO Option exercise +73,608 $12.55 $924K 1,272,726
2019-05-20 Polymeropoulos Mihael Hristos President and CEO Sale −67,418 $15.12 $1.0M 1,205,308

Page 16 of 20 · 387 trades